Distinguishing Melanoma From Other Skin Cancers

I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.

The first patient has received CX-801 plus Keytruda in a phase 1 trial for metastatic melanoma, aiming to assess safety and early antitumor activity.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

I would like to nominate Ashley Tullio, RN, for the Extraordinary Healer Award for Oncology Nursing.

New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.